2021 » Johns Hopkins Drug Discovery
page-template-default,page,page-id-2893,page-child,parent-pageid-21,ajax_fade,page_not_loaded,,qode-theme-ver-7.7,wpb-js-composer js-comp-ver-4.12.1,vc_responsive


184. Pham K, Maxwell MJ, Sweeney H, Alt J, Rais R, Eberhart CG, Slusher BS, Raabe EH. “Novel glutamine antagonist JHU-395 suppresses MYC-driven medulloblastoma growth and induces apoptosis”, J Neuropathol Exp Neurol, 80(4):336-344, 2021 [Pubmed]

183. Maynard RE, Poore B, Hanaford AR, Pham K, James M, Alt J, Park Y, Slusher BS, Tamayo P, Mesirov J, Archer TC, Pomeroy SL, Eberhart CG, Raabe EH. “TORC1/2 kinase inhibition depletes glutathione and synergizes with carboplatin to suppress the growth of C-MYC medulloblastoma”, Cancer Letters, 2021 [Pubmed

182. Su Y, DePasquale M, Liao G, Buchler I, Zhang G, Byers S, Carr GV, Barrow J, Wei J. “Membrane bound catechol-O-methyltransferase is the dominant isoform for dopamine metabolism in PC12 cells and rat brain”, Eur J Pharmacol, 2021 [Pubmed

181. Cabeza OA, Zhang Z, Khoury ES, Sheldon RA, Sharma A, Zhang F, Slusher BS, Kannan RM, Kannan S, Ferriero DM. “Neuroprotective effects of a dendrimer-based glutamate carboxypeptidase inhibitor on superoxide dismutase transgenic mice after neonatal hypoxic-ischemic brain injury”, Neurobiol Dis, 2021 [Pubmed

180. Harraz MM, Guha P, Kang IG, Semenza ER, Malla AP, Song YJ, Reilly L, Treisman I, Cortés P, Coggiano MA, Veeravalli V, Rais R, Tanda G, Snyder S. “Cocaine-induced locomotor stimulation involves autophagic degradation of the dopamine transporter”, Mol Psych, 2021 [Pubmed

179. Skácel J, Slusher BS, Tsukamoto T. “Small molecule inhibitors targeting biosynthesis of ceramide, the central hub of the sphingolipid network”, J Med Chem, 64(1):279-297, 2021 [Pubmed